Noropsikiyatri Arsivi-Archives of Neuropsychiatry

Scope & Guideline

Bridging Neuroscience and Psychiatry for Better Care

Introduction

Explore the comprehensive scope of Noropsikiyatri Arsivi-Archives of Neuropsychiatry through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Noropsikiyatri Arsivi-Archives of Neuropsychiatry in depth and align your research initiatives with current academic trends.
LanguageMulti-Language
ISSN1300-0667
PublisherTURKISH NEUROPSYCHIATRY ASSOC-TURK NOROPSIKIYATRI DERNEGI
Support Open AccessNo
CountryTurkey
TypeJournal
Convergefrom 1973 to 1974, from 1976 to 1977, from 1994 to 1995, from 2009 to 2024
AbbreviationNOROPSIKIYATRI ARS / Noropsikiyatri Ars.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressMESRUTIYET MAH HALASKARGAZI CAD SITE APT NO 128-1 SISLI, ISTANBUL 00000, Turkiye

Aims and Scopes

The journal 'Noropsikiyatri Arsivi-Archives of Neuropsychiatry' focuses on advancing knowledge in the fields of neuropsychiatry and mental health through a multidisciplinary approach. It aims to provide a platform for original research, reviews, and case studies that contribute to understanding the complexities of neuropsychiatric disorders and their treatments.
  1. Neuropsychiatric Disorders:
    Research on various neuropsychiatric conditions such as schizophrenia, bipolar disorder, major depression, and anxiety disorders, exploring their symptoms, underlying mechanisms, and treatment options.
  2. Neurodevelopmental Disorders:
    Investigation into conditions like autism spectrum disorder and ADHD, focusing on genetic, environmental, and psychosocial factors influencing their development and management.
  3. Neuroimaging and Biomarkers:
    Studies utilizing advanced imaging techniques and biomarkers to understand brain function and structure in relation to psychiatric conditions, aiding in diagnosis and treatment efficacy.
  4. Impact of COVID-19 on Mental Health:
    Research examining the psychological and neuropsychiatric effects of the COVID-19 pandemic, including its impact on patients with existing mental health conditions and the emergence of new symptoms.
  5. Innovative Treatment Approaches:
    Exploration of novel therapeutic strategies, including pharmacological, psychotherapeutic, and neuromodulation techniques, to enhance treatment outcomes for various neuropsychiatric disorders.
The journal has shown a dynamic evolution in its focus areas, with several themes gaining traction in recent publications. These emerging topics highlight the journal's responsiveness to current challenges in neuropsychiatry.
  1. Telepsychiatry and Remote Assessments:
    The rise of telepsychiatry has been a significant trend, particularly following the COVID-19 pandemic. Research on remote assessments and interventions is expanding, reflecting the need for accessible mental health care.
  2. Neuroinflammation and Psychiatric Disorders:
    An increasing number of studies are investigating the role of neuroinflammatory processes in psychiatric conditions, linking immune responses to mental health outcomes and treatment efficacy.
  3. Artificial Intelligence in Psychiatry:
    There is a growing interest in the application of artificial intelligence and machine learning techniques in diagnosing and predicting treatment responses in neuropsychiatric disorders.
  4. Psychosocial and Environmental Factors:
    Research is increasingly focusing on the influence of psychosocial stressors, trauma, and environmental factors on mental health, highlighting the importance of a holistic approach to understanding and treating these disorders.
  5. Genetic Studies and Personalized Medicine:
    Emerging research on genetic predispositions and the development of personalized treatment plans based on genetic and biomarker profiles is gaining prominence, indicating a shift towards tailored therapeutic strategies.

Declining or Waning

While the journal continues to explore a broad range of topics, certain themes appear to be declining in prominence over recent years. This may reflect shifting research priorities or emerging trends in neuropsychiatry.
  1. Traditional Psychopharmacology:
    Research focusing solely on conventional drug treatments for neuropsychiatric disorders seems to be waning, as there is a growing emphasis on integrated and holistic treatment approaches that consider psychological, social, and lifestyle factors.
  2. Case Reports of Rare Disorders:
    While case reports are valuable, there is a noticeable decline in the publication of case studies on rare neuropsychiatric disorders, possibly due to a shift towards larger cohort studies and systematic reviews.
  3. Solely Clinical Assessments:
    There is a decrease in papers that report only on clinical assessments without integrating neuroimaging or biomarker data, reflecting a trend towards more comprehensive, multidimensional approaches in research.

Similar Journals

Minerva Psychiatry

Connecting Practitioners and Researchers in Psychiatry
Publisher: EDIZIONI MINERVA MEDICAISSN: 2724-6612Frequency: 4 issues/year

Minerva Psychiatry is an innovative open-access journal published by EDIZIONI MINERVA MEDICA, focusing on the field of psychiatry and mental health. Launched in 2021, the journal aims to advance understanding and research in this critical area of medicine, serving as a platform for the dissemination of original research, clinical trials, and reviews that contribute to the improvement of mental health practices globally. With an ISSN of 2724-6612 and E-ISSN 2724-6108, this journal is situated in Italy and addresses a wide array of topics relevant to both practitioners and researchers in psychiatry. While the journal is currently ranked Q4 in its category, it seeks to enhance its impact by fostering high-quality submissions that address contemporary issues in mental health. Interested authors and readers can explore its publications through open access, encouraging a collective effort to elevate the standards and accessibility of psychiatric knowledge. With its commitment to nurturing a robust dialogue in the field, Minerva Psychiatry is positioned to become a valuable resource for those dedicated to mental health research and practice.

Asia-Pacific Psychiatry

Advancing Mental Health Knowledge Across the Asia-Pacific
Publisher: WILEYISSN: 1758-5864Frequency: 4 issues/year

Asia-Pacific Psychiatry is a leading academic journal published by WILEY, focused on the diverse and rapidly evolving fields of psychiatry and mental health within the Asia-Pacific region. With an ISSN of 1758-5864 and an E-ISSN of 1758-5872, this journal has been recognized for its significant impact, holding a Q1 ranking in Medicine (miscellaneous) and a Q2 ranking in Psychiatry and Mental Health as of 2023. Its commendable Scopus ranking places it at Rank #83 out of 567 in its category, highlighting its influence and relevance in contemporary research. The journal aims to facilitate the dissemination of high-quality research, reviews, and clinical insights that address mental health challenges, promote global understanding, and encourage collaboration among professionals and academics. Although it is not an open-access journal, the high impact factor underscores its value in the scholarly community, making it an essential resource for researchers, clinicians, and students dedicated to enhancing mental health practices and policies in the region and beyond.

Frontiers in Psychiatry

Innovating Solutions for Mental Well-being
Publisher: FRONTIERS MEDIA SAISSN: 1664-0640Frequency: 1 issue/year

Frontiers in Psychiatry is a leading journal dedicated to advancing research within the field of psychiatry and mental health. Published by FRONTIERS MEDIA SA, the journal has established a commendable reputation since its inception, reflected in its Q1 status in the 2023 Psychiatry and Mental Health category and a robust ranking of 142 out of 567 in the Scopus database. With an open access model initiated in 2009, Frontiers in Psychiatry aims to disseminate high-quality research to a global audience, fostering collaboration and innovation among researchers, clinicians, and students alike. The journal covers a broad spectrum of topics, including neurobiology, psychosocial factors, treatments, and public health implications of mental disorders, ensuring comprehensive representation of contemporary psychiatric science. Located in Lausanne, Switzerland, and running until 2024, the journal not only emphasizes the importance of mental health research but also encourages interdisciplinary discourse, making it an essential resource for anyone invested in the well-being of individuals and communities alike.

PSYCHIATRY AND CLINICAL NEUROSCIENCES

Fostering Understanding of Neurological and Psychiatric Disorders
Publisher: WILEYISSN: 1323-1316Frequency: 12 issues/year

PSYCHIATRY AND CLINICAL NEUROSCIENCES is a leading journal in the fields of psychiatry and clinical neurology, published by Wiley. With a commendable impact factor and a position within the prestigious Q1 quartile across multiple relevant categories—including Medicine (Miscellaneous), Neurology, and Psychiatry and Mental Health—this journal stands out for its rigorous peer-reviewed content that addresses critical issues in mental health and neurological disorders. Established in 1933, the journal has a rich history of contributing impactful research that guides both clinical practice and academic inquiry. Although it is not an open-access journal, its high relevance is underscored by its Scopus rankings, with notable percentiles in Psychiatry and Neurology, making it a vital resource for researchers, clinicians, and students looking to stay abreast of the latest advancements. Located in the United Kingdom, PSYCHIATRY AND CLINICAL NEUROSCIENCES aims to bridge the gap between theory and practical application, fostering a comprehensive understanding of the complex interplay between mental health and neurological conditions.

Klinik Psikiyatri Dergisi-Turkish Journal of Clinical Psychiatry

Advancing Mental Health Knowledge for All
Publisher: KLINIK PSIKIYATRI DERGISIISSN: 1302-0099Frequency: 4 issues/year

Klinik Psikiyatri Dergisi - Turkish Journal of Clinical Psychiatry is a distinguished open-access journal dedicated to the evolving field of psychiatry and mental health. Published by KLINIK PSIKIYATRI DERGISI in Turkey since 1998, this journal aims to provide a platform for the dissemination of research, clinical studies, and reviews that contribute to the understanding of psychological disorders and treatment methodologies. With an ISSN of 1302-0099 and an E-ISSN of 2146-7153, the journal is indexed in various databases, although it currently holds a rank of 460/567 in the Scopus ranking for the category of Medicine: Psychiatry and Mental Health. The journal operates under an open-access model, ensuring that research findings are readily accessible to a wide audience, contributing to greater knowledge and awareness in the field. As it converges from 2017 to 2024, Klinik Psikiyatri Dergisi continues to strive for excellence, providing valuable insights and resources for researchers, professionals, and students interested in the complexities of mental health.

EUROPEAN NEUROPSYCHOPHARMACOLOGY

Exploring Innovations in Neuropsychopharmacology
Publisher: ELSEVIERISSN: 0924-977XFrequency: 12 issues/year

EUROPEAN NEUROPSYCHOPHARMACOLOGY, published by Elsevier, is a prestigious academic journal that serves as a cornerstone in the field of neuropsychopharmacology, embracing multidisciplinary research at the intersection of neuroscience, psychiatry, and pharmacology. Since its establishment in 1990, this journal has consistently delivered cutting-edge research and reviews that drive forward our understanding of central nervous system disorders and their treatment. With an impressive impact factor and ranked in the Q1 category for several disciplines, including Biological Psychiatry and Neurology, it attracts submissions from leading researchers globally. The journal’s Scopus rankings reflect its significant influence, ranking in the top echelons across various categories such as Medicine and Neuroscience. While the journal maintains subscription access, readers are encouraged to explore the breadth of important findings that contribute to advancements in treatment options and improve patient care. EUROPEAN NEUROPSYCHOPHARMACOLOGY not only supports the dissemination of pivotal research but also fosters collaboration and dialogue within the scientific community, making it an essential resource for researchers, clinicians, and students dedicated to the complexities of brain health.

INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE

Connecting Clinical Practice with Psychiatric Insights
Publisher: SAGE PUBLICATIONS INCISSN: 0091-2174Frequency: 6 issues/year

INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE is a distinguished publication dedicated to advancing the understanding of psychiatric practice and mental health issues within a medical framework. Published by SAGE PUBLICATIONS INC, this journal has been a trusted source in the field since its inception, with its archives dating back to 1973. It offers a comprehensive exploration of psychiatric research, clinical studies, and theoretical advancements that seek to bridge the gap between psychiatry and general medicine. With an impact factor reflective of its quality and relevance, categorized in the Q3 quartile in Psychiatry and Mental Health, this journal stands as a vital resource for researchers, clinicians, and students alike. Although operating on a traditional subscription model, the extensive knowledge shared within its pages contributes significantly to ongoing discussions in psychiatric and mental health education and practice. As the field continually evolves, the INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE remains committed to fostering innovative and impactful scholarship that resonates with professionals navigating the complexities of mental health in clinical contexts.

ARQUIVOS DE NEURO-PSIQUIATRIA

Exploring Complexities in the Brain and Mind
Publisher: ASSOC ARQUIVOS NEURO- PSIQUIATRIAISSN: 0004-282XFrequency: 12 issues/year

ARQUIVOS DE NEURO-PSIQUIATRIA is a distinguished peer-reviewed journal that has been pivotal in advancing the fields of neuropsychiatry and neurology since its inception in 1945. Published by ASSOC ARQUIVOS NEURO-PSIQUIATRIA, this journal has established itself as a vital resource for researchers, professionals, and students in Brazil and beyond, with a commitment to open access since 2000, allowing broad dissemination of its findings. It boasts an E-ISSN of 1678-4227, continues to publish high-quality research, and is recognized in Scopus rankings, which place it in the Q4 quartile in Biological Psychiatry and Q3 in both Clinical Neurology and Neurology for 2023. The journal's address, located in the heart of São Paulo, reflects its commitment to fostering scientific dialogue within Brazil's vibrant research community. By focusing on the intersection of neurology and psychiatry, ARQUIVOS DE NEURO-PSIQUIATRIA aims to enrich our understanding of complex neurological disorders and psychiatric conditions, making it essential reading for those engaged in these critical areas of health research.

Cognitive Neuropsychiatry

Transforming Knowledge: The Intersection of Mind and Mental Health
Publisher: ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTDISSN: 1354-6805Frequency: 6 issues/year

Cognitive Neuropsychiatry is a distinguished academic journal published by Routledge Journals, Taylor & Francis Ltd, dedicated to the intersection of cognitive neuroscience and psychiatry. With a strong commitment to advancing knowledge in these rapidly evolving fields, this journal provides a platform for high-quality, peer-reviewed research that explores cognitive processes underlying psychiatric disorders. Aiming to bridge gaps between neuroscience and clinical practice, it serves as an essential resource for researchers, professionals, and students alike. As evidenced by its performance metrics, the journal ranks in the Q2 quartile for Psychiatry and Mental Health, and Q3 for Cognitive Neuroscience, showcasing its relevance and growing impact, particularly among a competitive audience. While it does not currently offer open access options, Cognitive Neuropsychiatry remains a vital outlet for disseminating impactful findings, offering insights that shape contemporary psychiatric understanding and interventions.

Brazilian Journal of Psychiatry

Fostering excellence in psychiatry for a global audience.
Publisher: ASSOC BRASILEIRA PSIQUIATRIAISSN: 1516-4446Frequency: 4 issues/year

The Brazilian Journal of Psychiatry is a prominent peer-reviewed journal dedicated to advancing the field of psychiatry and mental health, published by the Associação Brasileira de Psiquiatria. With an impressive Q2 ranking in the Psychiatry and Mental Health category for 2023 and a Scopus rank of #130 out of 567, this journal serves as a vital resource for researchers, clinicians, and students alike. Since its transition to Open Access in 1999, it has aimed to disseminate high-quality research, innovative practices, and critical insights relevant to mental health in Brazil and beyond. The journal's focus spans various topics in psychiatry, aiming to bridge the gap between research and clinical application, making it essential reading for professionals and academicians committed to improving mental health outcomes. With a commitment to fostering scholarly discourse, the Brazilian Journal of Psychiatry not only enriches the academic landscape but also enhances the practice of psychiatry through its widespread accessibility and dedication to excellence in research.